Elixxer Ltd. Announces $4 Million Secured Loan and Proposed Private Placement
MONTRÉAL, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or the “Company”) announces that it has entered into a loan agreement with AIP Convertible Private Debt Fund L.P. (the “Lender”) for a secured loan in the principal amount of CAD$4,000,000 (the “Loan”). The Loan will have a term of 24 months and will bear interest at the rate of 17% per annum. The Loan will be secured by a general security agreement on all of the present and after-acquired property of the Company.
On closing, the Company will pay to the Lender (i) a facility fee of CAD$200,000; (ii) a closing fee of CAD$250,000; and (ii) a monitoring fee of CAD$75,000, in respect of the Loan. Upon approval of the TSX Venture Exchange (the “TSXV”), the Lender shall also receive a bonus of 46,333,333 common shares (the “Bonus Shares”) of the Company at a deemed issue price of CAD$0.015 per share, representing 20% of the net amount of the Loan.
The Company intends to use the proceeds of the Loan for working capital purposes and to pursue future investments.
The Corporation also announces a proposed non-brokered private placement with a strategic investor in the amount of US$400,000 (USD/CAD exchange rate 1.307 for CAD $522,800) for 34,853,333 units of the Company (the “Units”) at a price of CAD$0.015 per Unit (the “Private Placement”). Each Unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will be exercisable for a period of 60 months from the date of issuance at an exercise price of CAD$0.05 each.
No commission or finder’s fee will be paid in connection with the Private Placement. The Units will be issued pursuant to an exemption from the prospectus requirements of applicable securities legislation, and all securities will be subject to a hold period of four months and one day from the date of issuance.
The proceeds of the Private Placement will be used by the Company for general working capital purposes. Closing of the Private Placement is subject to approval of the TSXV and to customary closing conditions.
Mazen Haddad, Elixxer CEO, stated, “We are very pleased to be working with AIP. This financing is intended to allow Elixxer to execute on our acquisition strategy which will target growth companies with revenues and cashflows.”
About Elixxer Ltd. ()
Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).
Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.
For further information please contact:
Mazen Haddad, CEO:
Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice Regarding Forward Looking Statements
This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in Elixxer’s most recent Management’s Discussion and Analysis filed on SEDAR (). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.
